Overcoming the ‘hypoglycemia side effect,’ basal insulin have newly emerged in 7 years

Basal insulin are going to be newly launched in the domestic market in 7 years. They have secured both long-acting effectiveness and convenience to only administer once a week.

However, an unfavorable part for the products is that insulin injections are less frequently used than oral drugs.

Pharmaceutical companies which will launch next-generation basal insulin in 7 years, thus, have excepti...